Dermatology Times, January 2023 (Vol. 44. No. 01)

An expert dermatologist reviews generalized pustular psoriasis in 2 patients and how he would approach treatment and management.

Dermatologists have long warned tan seekers about the detrimental effects of ultraviolet exposure and tanning beds, strongly discouraging their use; nasal tanning sprays are no different.

Numerous over-the-counter (OTC) nutritional supplements appear effective in treating hair loss, according to a systematic review published in JAMA Dermatology.

The long-believed causal association between inflammatory bowel disease and both psoriasis and psoriatic arthritis has been recently confirmed.

Two specialists discuss prevalence, patient communication, and exciting new therapy.

JAK inhibitors may cause less adverse events compared with traditional systemic therapies.

Breakthroughs and approvals we can expect in the coming year.

Your practice’s finances are the key to long-term business success and understanding them doesn’t have to feel like a puzzle.

In this month's Cosmetic Conundrums columns, Zoe Diana Draelos, MD, reveals how to solve tricky nail problems.

This month's Legal Eagle column reviews how a patient tried to sue for battery due to excess swelling after dermal fillers.

Phototherapy can serve an important role in the therapeutic armamentarium of vitiligo as it is safe, cost-effective, and can treat patients with large areas of disease.

Arthritis mutilans, often called resorptive arthritis, is the most severe and rare form of psoriatic arthritis, affecting only about 5-16% of patients.

A recent systematic review on surgical therapies for vitiligo examined surgical therapies such as punch grafting, suction blister epidermal grafting, and cellular grafting techniques

Vitiligo, an autoimmune skin condition that causes depigmentation, can have a large effect on a patient’s quality of life and psychosocial well-being.

Accure’s system is the first 1726nm-based laser device with both FDA and CE Mark clearances.

Andrew Alexis, MD, shares his best tips for appropriate laser use in skin of color patients at the 2022 SDPA Conference.

A poster presentation from the 2022 SDPA Conference reviewed an elastic-scattering spectroscopy device for melanoma detection.

Using pooled 52-week results from TRuE-AD1 and TRuE-AD2, investigators examined how the topical JAK1/JAK 2 inhibitor affects patient feelings of skin pain, discomfort, anxiety, and depression.

Dermavant announced positive results from its pediatric maximal usage study.

Will Kirby, DO, FAOCD, talks with Dustin Portela, DO, FAAD, about TikTok, what being a KOL really means, and the biggest aesthetic myth in the industry right now.